IGF-1R SIGNALING PATHWAY INHIBITORS USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

• 收藏
• 分享

专利权人:

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM; LTD.

发明人:

Hadas REUVENI,Ehud COHEN,Alexander LEVITZKI,Shmuel BEN-SASSON

申请号：

US14904787

公开号：

US20160158243A1

申请日:

2014.07.13

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The present invention provides compounds acting as Insulin/IGF signaling modulators useful in the treatment of neurodegenerative diseases and disorders. The invention provides pharmaceutical compositions including such compounds, and methods of using these compounds and compositions for the treatment of neurodegenerative diseases, in particular neurodegenerative diseases caused by proteotoxicity such as Alzheimer's disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/